Two Vaccines for <italic toggle="yes">Staphylococcus aureus</italic> Induce a B-Cell-Mediated Immune Response
ABSTRACT Staphylococcus aureus causes severe disease in humans for which no licensed vaccine exists. A novel S. aureus vaccine (SA4Ag) is in development, targeting the capsular polysaccharides (CPs) and two virulence-associated surface proteins. Vaccine-elicited antibody responses to CPs are efficac...
Guardado en:
Autores principales: | Christopher D. Dupont, Ingrid L. Scully, Ross M. Zimnisky, Brinda Monian, Christina P. Rossitto, Ellen B. O'Connell, Kathrin U. Jansen, Annaliesa S. Anderson, J. Christopher Love |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec62c241bbc54b0ca93bc9305e01660a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MntC-Dependent Manganese Transport Is Essential for <italic toggle="yes">Staphylococcus aureus</italic> Oxidative Stress Resistance and Virulence
por: Luke D. Handke, et al.
Publicado: (2018) -
<named-content content-type="genus-species">Staphylococcus aureus</named-content> Clumping Factor A Remains a Viable Vaccine Target for Prevention of <named-content content-type="genus-species">S. aureus</named-content> Infection
por: Annaliesa S. Anderson, et al.
Publicado: (2016) -
Regulation of Staphylococcus aureus MntC expression and its role in response to oxidative stress.
por: Luke D Handke, et al.
Publicado: (2013) -
Stable Signal Peptides and the Response to Secretion Stress in <italic toggle="yes">Staphylococcus aureus</italic>
por: Arryn Craney, et al.
Publicado: (2017) -
<italic toggle="yes">Staphylococcus aureus</italic> Responds to the Central Metabolite Pyruvate To Regulate Virulence
por: Lamia Harper, et al.
Publicado: (2018)